RGRX (Regenerx Biopharmaceuticals) General and Admin. Expense: $1.44 Mil (TTM As of Mar. 2023)


What is Regenerx Biopharmaceuticals General and Admin. Expense?

Regenerx Biopharmaceuticals RGRX General and Admin. Expense is $1.44 Mil as of Mar. 2023.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Regenerx Biopharmaceuticals's General and Admin. Expense for the three months ended in Mar. 2023 was $0.32 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2023 was $1.44 Mil.

Regenerx Biopharmaceuticals General and Admin. Expense Related Terms

Regenerx Biopharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Regenerx Biopharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Regenerx Biopharmaceuticals General and Admin. Expense Chart

Regenerx Biopharmaceuticals Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.31 1.27 1.37 1.40 1.48

Regenerx Biopharmaceuticals Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 0.48 0.30 0.33 0.32

Regenerx Biopharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $1.44 Mil mean?
Regenerx Biopharmaceuticals (RGRX) has a General and Admin. Expense of $1.44 Mil as of Mar. 2023. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Regenerx Biopharmaceuticals and its competitors.
Is Regenerx Biopharmaceuticals' General and Admin. Expense too high?
Regenerx Biopharmaceuticals' current General and Admin. Expense is $1.44 Mil.
How does Regenerx Biopharmaceuticals' General and Admin. Expense compare to MYMX and RGMP?
Regenerx Biopharmaceuticals' General and Admin. Expense of $1.44 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Regenerx Biopharmaceuticals and its competitors. Regenerx Biopharmaceuticals's current General and Admin. Expense is $1.44 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Regenerx Biopharmaceuticals stock overvalued right now?
Regenerx Biopharmaceuticals (RGRX) has a current General and Admin. Expense of $1.44 Mil. The current General and Admin. Expense is $1.44 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Regenerx Biopharmaceuticals (RGRX), the current General and Admin. Expense is $1.44 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Regenerx Biopharmaceuticals Business Description

Address 15245 Shady Grove Road, Suite 470, Rockville, MD, USA, 20850
Regenerx Biopharmaceuticals Inc is focused on the discovery and development of novel molecules to accelerate tissue and organ repair. Its operations are confined to one business segment: the development and marketing of product candidates based on Thymosin Beta 4 (Tß4), an amino acid peptide. The company has formulated Tß4 into three distinct product candidates in clinical development: RGN-259, a preservative-free topical eye drop for regeneration of corneal tissues damaged by injury, disease or other pathology; RGN-137, a topical gel for dermal wounds and reduction of scar tissue; and RGN-352, an injectable formulation to treat cardiovascular diseases, central and peripheral nervous system diseases, and other medical indications that may be treated by systemic administration.